Testogel® 16.2 mg/g gel is indicated in adults as testosterone therapy (TTh) for male hypogonadism when testosterone deficiency (TD) has been confirmed by clinical features and biochemical tests.1
The recommended daily dose is two actuations. The pump enables the prescriber to easily adjust the dose if required.*1
Normal testosterone levels** were achieved at day 182 in 82.2% (139/169) of testosterone deficient men treated with an optimised dose vs. 28.6% of men receiving placebo in a randomised placebo-controlled trial involving 274 patients.1,2
Well tolerated: 1–10% incidence of skin reactions.1
Please refer to the safety information for further details regarding undesirable side effects.
Comprehensive online support for patients that aims to instil confident, regular use of treatment.